Quote | Sensei Biotherapeutics Inc. (NASDAQ:SNSE)
Last: | $1.05 |
---|---|
Change Percent: | -2.75% |
Open: | $1.12 |
Close: | $1.05 |
High: | $1.12 |
Low: | $1.05 |
Volume: | 16,941 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Sensei Biotherapeutics Inc. (NASDAQ:SNSE)
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will participate on a panel titled...
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that the company will present preclinical data on its cond...
Message Board Posts | Sensei Biotherapeutics Inc. (NASDAQ:SNSE)
Subject | By | Source | When |
---|---|---|---|
Anyone else looking at this company? Small anti-aging | Clemdane | investorshub | 03/03/2023 1:29:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Sensei Biotherapeutics Inc. Company Name:
SNSE Stock Symbol:
NASDAQ Market:
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the d...
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will participate on a panel titled...
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the d...